AcouSort AB Stock price

Equities

ACOU

SE0009189608

Biotechnology & Medical Research

Delayed Nasdaq Stockholm 06:14:44 2024-03-28 am EDT 5-day change 1st Jan Change
10.6 SEK +1.44% Intraday chart for AcouSort AB -3.20% -31.83%
Sales 2021 5.96M 556K Sales 2022 8.58M 801K Capitalization 196M 18.31M
Net income 2021 -12M -1.12M Net income 2022 -13M -1.21M EV / Sales 2021 51.4 x
Net cash position 2021 31.52M 2.94M Net cash position 2022 34.43M 3.21M EV / Sales 2022 18.8 x
P/E ratio 2021
-27.7 x
P/E ratio 2022
-14.2 x
Employees 14
Yield 2021 *
-
Yield 2022
-
Free-Float 59.1%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.44%
1 week-3.20%
Current month-15.87%
1 month-21.48%
3 months-32.70%
6 months-61.73%
Current year-31.83%
More quotes
1 week
9.60
Extreme 9.6
10.90
1 month
9.40
Extreme 9.4
13.50
Current year
9.40
Extreme 9.4
16.90
1 year
9.40
Extreme 9.4
28.60
3 years
9.40
Extreme 9.4
32.95
5 years
5.32
Extreme 5.32
32.95
10 years
5.32
Extreme 5.32
32.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 13-12-31
Director of Finance/CFO 63 15-12-31
Members of the board TitleAgeSince
Director/Board Member - 21-11-30
Founder 63 10-12-31
Chairman 55 21-04-27
More insiders
Date Price Change Volume
24-03-28 10.6 +1.44% 20 084
24-03-27 10.45 +2.45% 35,889
24-03-26 10.2 +0.49% 10,647
24-03-25 10.15 -3.79% 7,032
24-03-22 10.55 -3.65% 18,506

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 06:14 am EDT

More quotes
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock AcouSort AB - Nasdaq Stockholm